Immunotech Biopharm’s CAR-T-19-D2 IND Filing Accepted by NMPA
China-based chimeric antigen receptor T-cell (CAR-T) specialist Immunotech Biopharm Ltd (HKG: 6978) has announced that...
Acotec Scientific Holdings Receives NMPA Approvals for YAN and P-Conic Balloon
China-based Acotec Scientific Holdings Ltd (HKG: 6669) has announced receiving market approvals from the National...
CanSino Biologics Updates Data from COVID-19 Vaccine Clinical Studies
China-based CanSino Biologics (HKG: 6185) has provided data updates from three clinical studies for its...
Fortune Care Raises Over RMB 100 Million in Series C+ Financing Round
China-based household healthcare and nursing brand Fortune Care reportedly raised over RMB 100 million (USD...
Guangzhou Mygene Raises ‘Hundreds of Millions’ in Series C Financing Led by Efund Capital
China-based molecular diagnostic product developer Guangzhou Mygene Medical Technology Co., Ltd reportedly raised “hundreds of...
WuXi Biologics Receives First GMP Certificate from Ireland HPRA
China-based Contract Research, Development, and Manufacturing Organization (CRDMO) WuXi Biologics (HKG: 2269) has announced receiving...
CARsgen Develops New CAR-T Technique to Enhance Anti-Tumor Activity
China-based chimeric antigen receptor (CAR)-T cell specialist CARsgen Therapeutics Holdings Ltd (HKG: 2171) has announced...
SciClone Pharmaceuticals’ Vaborem IND Filing Accepted by NMPA
SciClone Pharmaceuticals Inc (HKG: 6600) has announced that an Investigational New Drug (IND) filing for...
Luye Pharma’s Paliperidone Palmitate Accepted for NMPA Review
China-based Luye Pharma Group (HKG: 2186) has announced that the market filing for its paliperidone...
China Downgrades COVID-19 from Class A to Class B Infectious Disease
The National Health Commission (NHC) has issued a notice downgrading COVID-19 from a Class A...
Carrier Biomed Raises ‘Tens of Millions’ in Series A+ Financing Round
Carrier Biomed (Soohow) Co., Ltd, an exosome technology developer based in Suzhou, has reportedly raised...
Everest Medicines Launches First Phase of Global mRNA Vaccine Manufacturing Site
China-based Everest Medicines (HKG: 1952) has announced the initiation of the operation of the first...
InnoCare Pharma Receives Hong Kong Approval for Tafasitamab in DLBCL
China-based biopharma InnoCare Pharma (HKG: 9969, SHA: 688428) has announced receiving market approval from the...
LeadArt Biotechnologies Raises USD 6 Million in Pre-Series A Round
LeadArt Biotechnologies Inc., a chemical proteomics specialist based in Ningbo, has reportedly raised close to...
Simcere Receives NMPA Clearance for SIM0237 Clinical Study
China-based Simcere Pharmaceutical Group (HKG: 2096) has announced receiving clearance from the National Medical Products...
CStone Pharmaceuticals Publishes Ayvakit Study Results on Oncologist Website
China-based CStone Pharmaceuticals (HKG: 2616) has published the results of the China-based bridging NAVIGATOR study...
Biosion Completes Series B Financing Round Led by Guangfa Xinde Investment
Biosion, a global, clinical-stage biotech committed to developing antibody-based therapies targeting immune and oncologic diseases,...
BGI Genomics Receives ANVISA Approval for Colorectal Cancer Detection Kit
China-based genomics giant BGI Genomics Co., Ltd (SHE: 300676) has reported receiving product approval from...
InflaRx and Staidson Amend Deal to Advance Vilobelimab Regulatory Filing in China
Germany-based biopharma InflaRx N.V. (Nasdaq: IFRX) has revealed an amendment to its underlying deal with...
Elpiscience Receives IND Approval for ES014 in China
Shanghai-based Elpiscience Biopharmaceuticals Inc. has announced receiving Investigational New Drug (IND) approval in China to...